Clinical Trial Update: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis [Phase 1, Phase 2]

View source ↗

Summary

It reports the completion of a Phase 1/Phase 2 trial of YN001 in healthy subjects and patients with atherosclerotic cardiovascular disease (coronary atheroscler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease

Drugs mentioned

• YN001

Snippet

Sponsor: Beijing Inno Medicine Co., Ltd. | Conditions: Atherosclerotic Cardiovascular Disease | Phase 1, Phase 2 | Status: COMPLETED